Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Micro- and nanoparticulates.

Andrew A Moshfeghi1, Gholam A Peyman

  • 1Bascom Palmer Eye Institute, 900 NW 17th St Miami, FL 33136, USA. amoshfeghi@med.miami.edu

Advanced Drug Delivery Reviews
|November 22, 2005
PubMed
Summary

Micro- and nano-particulates show promise as novel drug delivery systems for neovascular age-related macular degeneration (AMD). These advanced materials are being explored for targeted therapies to improve treatment outcomes in AMD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Universal Newborn Eye Screening in São Paulo, Brazil.

Ophthalmic surgery, lasers & imaging retina·2026
Same author

The Association of Retinal Capillary Density and Retinal Thickness in Diabetic Retinopathy.

Investigative ophthalmology & visual science·2025
Same author

Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice.

BMC ophthalmology·2024
Same author

Accuracy of an objective binocular automated phoropter for providing spectacle prescriptions.

Clinical & experimental optometry·2023
Same author

Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy.

BMJ open ophthalmology·2023
Same author

Visual Acuity Outcomes in Patients Receiving Frequent Treatment of Neovascular Age-Related Macular Degeneration in Clinical Practice.

Journal of vitreoretinal diseases·2023

Area of Science:

  • Ophthalmology
  • Materials Science
  • Pharmacology

Background:

  • Pharmacotherapeutics is crucial for managing neovascular age-related macular degeneration (AMD).
  • Micro- and nano-particulates are emerging as potential drug delivery vehicles for AMD treatment.

Purpose of the Study:

  • To review the experimental use of micro- and nano-particulates in neovascular AMD.
  • To explore the potential clinical applications of these drug delivery systems.

Main Methods:

  • Literature review of pre-clinical studies.
  • Analysis of experimental models for neovascular AMD.

Main Results:

  • Micro- and nano-particulates have been primarily utilized in pre-clinical settings.
  • These particulates serve as novel drug delivery devices in experimental neovascular AMD models.

Conclusions:

  • Micro- and nano-particulates are expected to be integral to future targeted pharmacotherapeutics for neovascular AMD.
  • These advanced delivery systems hold significant potential for clinical application in AMD management.

Related Experiment Videos